Full-length MSP1 is a major target of protective immunity after controlled human malaria infection. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202301910
PubMed Identifier: 38803222
Publication URI: http://europepmc.org/abstract/MED/38803222
Type: Journal Article/Review
Volume: 7
Parent Publication: Life science alliance
Issue: 8
ISSN: 2575-1077